RAIsonance, Inc. Announces BARDA Contract to Continue Development of the AudibleHealth Dx Diagnostic SaMD for COVID-19 and Influenza Through AI-Powered Cough Analysis

RAIsonance’s Forced Cough Vocalization (FCV) Signature Analysis Technology is Designed to Diagnose Respiratory Illnesses Via a Cloud-Based Diagnostic Platform and a Mobile App User Interface DENVER, April 12, 2023 /PRNewswire/ — RAIsonance, Inc., the leader in artificial…